Logical Biological has settled into larger, upgraded laboratory space at Discovery Park, marking its third move within the science and innovation campus.
As part of the group's GreenUp strategic plan, Veolia Water Technologies is opening this centre to drive water treatment innovation, growth and training in Europe and beyond for the pharmaceutical, science and healthcare markets.
The expansion includes increased production capacity at ACG Capsules’ Croatian facility and the opening of new warehousing and slitting facilities by ACG Packaging Materials division.
PCI Pharma Services, (“PCI”) a global contract development and manufacturing organisation (CDMO) focused on biopharma’s most complex therapies, is investing more than $365 million in infrastructure.
Specialising in pharmaceuticals, the site offers a variety of services including mixing and blending, storage, transportation, and quality-assured repackaging of active ingredients.
Johnson & Johnson Innovative Medicine have announced its strengthened commitment in Italy, with a projected investment of 580 million euros over the next five years, of which €125 million will support an increase in production capacity.
Eli Lilly and Company have announced that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion.
To discuss the recent news from Exothera that the company are expand into North America, we at EPM caught up with Darren Leva, Chief Business Officer, Exothera.
